91 results
8-K
EX-99.1
CYTK
Cytokinetics Inc
8 May 24
Cytokinetics Reports First Quarter 2024 Financial Results
4:05pm
or a marketing authorisation application for aficamten in the European Union in the fourth quarter of 2024, our ability to complete enrollment of MAPLE-HCM
8-K
EX-99.1
CYTK
Cytokinetics Inc
27 Feb 24
Cytokinetics Reports Fourth Quarter 2023 Financial Results
4:05pm
for aficamten in the United States or a marketing authorisation application for aficamten in the European Union, our ability to obtain approval of our
8-K
EX-1.1
et29 ix7olaczdm
21 Jul 21
Results of Operations and Financial Condition
4:25pm